326 related articles for article (PubMed ID: 25961454)
1. Inducible Gata1 suppression expands megakaryocyte-erythroid progenitors from embryonic stem cells.
Noh JY; Gandre-Babbe S; Wang Y; Hayes V; Yao Y; Gadue P; Sullivan SK; Chou ST; Machlus KR; Italiano JE; Kyba M; Finkelstein D; Ulirsch JC; Sankaran VG; French DL; Poncz M; Weiss MJ
J Clin Invest; 2015 Jun; 125(6):2369-74. PubMed ID: 25961454
[TBL] [Abstract][Full Text] [Related]
2. Embryonic stem cells as sources of donor-independent platelets.
Canver MC; Bauer DE; Orkin SH
J Clin Invest; 2015 Jun; 125(6):2261-3. PubMed ID: 25961451
[TBL] [Abstract][Full Text] [Related]
3. The Gata1
Shin E; Jeong JG; Chung H; Jung H; Park C; Yoon SR; Kim TD; Lee SJ; Choi I; Noh JY
Biochem Biophys Res Commun; 2020 Jul; 528(1):46-53. PubMed ID: 32456797
[TBL] [Abstract][Full Text] [Related]
4. Repercussion of Megakaryocyte-Specific Gata1 Loss on Megakaryopoiesis and the Hematopoietic Precursor Compartment.
Meinders M; Hoogenboezem M; Scheenstra MR; De Cuyper IM; Papadopoulos P; Németh T; Mócsai A; van den Berg TK; Kuijpers TW; Gutiérrez L
PLoS One; 2016; 11(5):e0154342. PubMed ID: 27152938
[TBL] [Abstract][Full Text] [Related]
5. Lineage-specific combinatorial action of enhancers regulates mouse erythroid Gata1 expression.
Drissen R; Guyot B; Zhang L; Atzberger A; Sloane-Stanley J; Wood B; Porcher C; Vyas P
Blood; 2010 Apr; 115(17):3463-71. PubMed ID: 20154211
[TBL] [Abstract][Full Text] [Related]
6. Transcription Factor Levels after Forward Programming of Human Pluripotent Stem Cells with GATA1, FLI1, and TAL1 Determine Megakaryocyte versus Erythroid Cell Fate Decision.
Dalby A; Ballester-Beltrán J; Lincetto C; Mueller A; Foad N; Evans A; Baye J; Turro E; Moreau T; Tijssen MR; Ghevaert C
Stem Cell Reports; 2018 Dec; 11(6):1462-1478. PubMed ID: 30503262
[TBL] [Abstract][Full Text] [Related]
7. Thrombopoietin induces megakaryocyte differentiation in hematopoietic progenitor FDC-P2 cells.
Nagata Y; Nagahisa H; Aida Y; Okutomi K; Nagasawa T; Todokoro K
J Biol Chem; 1995 Aug; 270(34):19673-5. PubMed ID: 7649975
[TBL] [Abstract][Full Text] [Related]
8. Thrombopoietin enhances generation of CD34+ cells from human embryonic stem cells.
Srivastava AS; Nedelcu E; Esmaeli-Azad B; Mishra R; Carrier E
Stem Cells; 2007 Jun; 25(6):1456-61. PubMed ID: 17379761
[TBL] [Abstract][Full Text] [Related]
9. Expandable megakaryocyte cell lines enable clinically applicable generation of platelets from human induced pluripotent stem cells.
Nakamura S; Takayama N; Hirata S; Seo H; Endo H; Ochi K; Fujita K; Koike T; Harimoto K; Dohda T; Watanabe A; Okita K; Takahashi N; Sawaguchi A; Yamanaka S; Nakauchi H; Nishimura S; Eto K
Cell Stem Cell; 2014 Apr; 14(4):535-48. PubMed ID: 24529595
[TBL] [Abstract][Full Text] [Related]
10. The relative population sizes of megakaryocytic cells in mouse bone marrow as determined by mpl ligand responsiveness.
Mintern J; Williams N; Jackson H
Exp Hematol; 1997 Nov; 25(12):1233-9. PubMed ID: 9357966
[TBL] [Abstract][Full Text] [Related]
11. Early block to erythromegakaryocytic development conferred by loss of transcription factor GATA-1.
Stachura DL; Chou ST; Weiss MJ
Blood; 2006 Jan; 107(1):87-97. PubMed ID: 16144799
[TBL] [Abstract][Full Text] [Related]
12. A role of jumonji gene in proliferation but not differentiation of megakaryocyte lineage cells.
Kitajima K; Kojima M; Kondo S; Takeuchi T
Exp Hematol; 2001 Apr; 29(4):507-14. PubMed ID: 11301191
[TBL] [Abstract][Full Text] [Related]
13. Preferential ex vivo expansion of megakaryocytes from human cord blood CD34+-enriched cells in the presence of thrombopoietin and limiting amounts of stem cell factor and Flt-3 ligand.
Proulx C; Boyer L; Hurnanen DR; Lemieux R
J Hematother Stem Cell Res; 2003 Apr; 12(2):179-88. PubMed ID: 12804177
[TBL] [Abstract][Full Text] [Related]
14. The end is just the beginning: megakaryocyte apoptosis and platelet release.
Li J; Kuter DJ
Int J Hematol; 2001 Dec; 74(4):365-74. PubMed ID: 11794690
[TBL] [Abstract][Full Text] [Related]
15. Novel hematopoietic progenitor populations revealed by direct assessment of GATA1 protein expression and cMPL signaling events.
Heffner GC; Clutter MR; Nolan GP; Weissman IL
Stem Cells; 2011 Nov; 29(11):1774-82. PubMed ID: 21898686
[TBL] [Abstract][Full Text] [Related]
16. FOG1 requires NuRD to promote hematopoiesis and maintain lineage fidelity within the megakaryocytic-erythroid compartment.
Gregory GD; Miccio A; Bersenev A; Wang Y; Hong W; Zhang Z; Poncz M; Tong W; Blobel GA
Blood; 2010 Mar; 115(11):2156-66. PubMed ID: 20065294
[TBL] [Abstract][Full Text] [Related]
17. Thrombopoietin: biology and clinical potentials.
Miyazaki H; Kato T
Int J Hematol; 1999 Dec; 70(4):216-25. PubMed ID: 10643146
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Short Variant Form of New Kelch Family Protein Leads to Erythroid and Megakaryocyte Dysplasia by Targeting Megakaryocyte-Erythroid Progenitors.
Lin Y; Luo Y; Hu F; Wang T; Dong Y; Yang D; He X; Chen X; Wang J; Du J; Zhang X
DNA Cell Biol; 2018 Oct; 37(10):831-838. PubMed ID: 30124330
[TBL] [Abstract][Full Text] [Related]
19. Pluripotent stem cell model of early hematopoiesis in Down syndrome reveals quantitative effects of short-form GATA1 protein on lineage specification.
Matsuo S; Nishinaka-Arai Y; Kazuki Y; Oshimura M; Nakahata T; Niwa A; Saito MK
PLoS One; 2021; 16(3):e0247595. PubMed ID: 33780474
[TBL] [Abstract][Full Text] [Related]
20. Thrombopoietin: understanding and manipulating platelet production.
Kaushansky K
Annu Rev Med; 1997; 48():1-11. PubMed ID: 9046940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
